Per Soelberg Sørensen
Professor emeritus, Professor, emeritus
- Published
Early safety and efficacy of fingolimod treatment in Denmark
Voldsgaard, A., Koch-Henriksen, N., Magyari, M., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg & Oturai, A. B., Jan 2017, In: Acta Neurologica Scandinavica. 135, 1, p. 129-133 5 p.Research output: Contribution to journal › Journal article › Research
- Published
Trichurs suis ova theraphy in relapsing multiple sclerosis is safe but without signals of beneficial effect
Voldsgaard, A., Bager, P., Garde, E., Åkeson, P., Leffers, A. M., Madsen, C. G., Kapel, Christian, Thamsborg, Stig Milan, Roepstorff, A. K., Melbye, M., Siebner, Hartwig Roman, Søndergaard, H. B., Sellebjerg, F. & Sørensen, Per Soelberg, 2015, In: Multiple Sclerosis Journal. 21, 13, 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
Vollmer, T. L., Sørensen, Per Soelberg, Selmaj, K., Zipp, F., Havrdova, E., Cohen, J. A., Sasson, N., Gilgun-Sherki, Y., Arnold, D. L. & BRAVO Study Group, B. S. G., Apr 2014, In: Journal of Neurology. 261, 4, p. 773-783 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting
Vorstrup, S., Christensen, J., Gjerris, F., Sørensen, Per Soelberg, Thomsen, A. M. & Paulson, Olaf B., Mar 1987, In: Journal of Neurosurgery. 66, 3, p. 379-87 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis
Wu, X., Hanson, L. G., Skimminge, A., Sørensen, Per Soelberg, Paulson, Olaf B., Mathiesen, H. K. & Blinkenberg, M., Aug 2014, In: Neurological Research. 36, 8, p. 701-708 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis
Yu, H., Graham, G., David, O. J., Kahn, J. M., Savelieva, M., Pigeolet, E., Das Gupta, A., Pingili, R., Willi, R., Ramanathan, K., Kieseier, B. C., Häring, D. A., Bagger, M. & Sørensen, Per Soelberg, 2022, In: CNS Drugs. 36, 3, p. 283-300 18 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 11025
Most downloads
-
240
downloads
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
184
downloads
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
160
downloads
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
Research output: Contribution to journal › Journal article › Research › peer-review
Published